Understand the source comparison
SS-LUP-332 Peptide vs Other Mitochondrial Modulators: Performance Comparison
Before evaluating SS-LUP-332 peptide for research applications, understanding how it compares to established mitochondrial compounds clarifies its specific niche. The table below contrasts SS-LUP-332 peptide with three alternative mitochondrial modulators acro
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before evaluating SS-LUP-332 peptide for research applications, understanding how it compares to established mitochondrial compounds clarifies its specific niche. The table below contrasts SS-LUP-332 peptide with three alternative mitochondrial modulators across mechanism, evidence base, and practical considerations.
- SS-LUP-332 Peptide
- Complex I stabilisation, reduced proton leak
- 22% increase in time to exhaustion (mice, 28 days)
- Limited to 28-day rodent studies; no human data
- Available from research peptide suppliers; not FDA-approved
- Emerging mitochondrial modulator with narrow evidence base. Mechanism is novel but long-term effects unknown
- AICAR
- AMPK activation, mimics exercise signalling
- 44% increase in endurance capacity (mice, 4 weeks)
- Hepatotoxicity at high doses; purine metabolism disruption
- Widely available as research chemical
- Potent AMPK activator with stronger performance data but significant toxicity concerns
- MitoQ
- Mitochondrial-targeted antioxidant (CoQ10 derivative)
- No endurance increase; reduces oxidative damage markers
- Well-tolerated in human trials up to 12 months
- Available as dietary supplement and research-grade
- Antioxidant, not performance enhancer. Different mechanism entirely
- Nicotinamide Riboside (NR)
- NAD+ precursor, supports mitochondrial biogenesis
- 12–18% increase in mitochondrial density (human trials)
- Safe in human trials; mild flushing at >1000mg/day
- Available as supplement; research-grade from suppliers
- Human-validated NAD+ booster with modest mitochondrial effects. Works upstream of SS-LUP-332 peptide